Fiche Société BIOTALYS


Intégrer ceci à votre site/blog

Astuce: Pour zoomer, cliquer sans relâcher puis dessiner un rectange.

Liste des actualités sur un an

JourDateTitreEffet sur
le cours		CAC40
18/03/202407:00And novonesis announce manufacturing and commercialisation partnership for evoca ng+18.34%-0.2%
29/11/202306:00Provides company update+16.62%+0.24%
05/10/202306:00Kevin helash commences role as chief executive officer of biotalys+3.67%+0.02%
02/10/202306:00Announces the appointment of kevin helash as chief executive officer and director to lead the company in its next growth phase-8.3%-0.94%
23/08/202306:00Reports half-year 2023 financial results and business highlights-1.68%+0.08%
20/07/202306:00Invitation to a special shareholders' meeting+1%+0.79%
24/03/202307:00Invitation to the annual and an extraordinary shareholders meeting+0.98%-1.74%
26/01/202306:00Achieves significant progress in manufacturing capabilities for evoca+1.16%+0.74%
25/11/202206:00Invitation to an extraordinary shareholders' meeting+0.31%+0.08%
07/11/202206:00Announces participation at investor and industry events for the remainder of 2022+2.08%+0%
24/10/202206:00And novozymes announce successful evoca™ feasibility study0%+1.59%
13/09/202206:00Announces participation at investor and industry events for the upcoming months+0%-1.39%
19/08/202206:00Reports half-year 2022 financial results and business highlights+1.39%-0.94%
21/06/202206:00And novozymes enter into partnership to expand opportunities for evoca™-0.28%+0.75%
20/05/202207:00Dévoile les résultats prometteurs de ses derniers essais sur le terrain avec son biocontrôle evoca+1.13%+0.2%
03/05/202206:00Obtains new fungicide resistance class for its first biofungicide+1.65%+0.79%
19/04/202206:00Appoints michiel van lookeren campagne to board of directors+0%-0.83%
16:59 (J-4)Results of the annual and extraordinary shareholders' meetings
27/01/202206:00Appoints kwizda agro as formulator of its protein-based biocontrols+2.86%+0.6%
25/01/202206:00Achieves breakthrough in protein expression increasing commercial potential for its first biofungicide evoca+0.86%+0.74%
12/01/202206:00And olon enter into long-term partnership for the production of protein-based biocontrols+1.66%+0.75%
20/10/202106:00Awarded multi-year grant to develop new biological solutions for cowpea and other legumes+8.08%+0.54%
30/09/202106:00Strengthens executive team with the appointment of patrick mcdonnell as chief business officer-1.13%-0.62%
17/09/202110:07Le directeur scientifique de biotalys quitte ses fonctions+0.54%-0.79%
06:00Board and executive changes
06:00Reports half-year 2021 financial results and business highlights
24/08/202106:00Notice of half year 2021 results+0.52%-0.28%
15/07/202106:00Publication of transparency notifications+-0.53%-0.99%